INS and polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial focused on the impact of Kuntai capsule in subjects with PCOS found out a significant decrease in total cholesterol (TC), triglyceride (TG), and low-density lipoprotein level, as well as insulin and homeostasis model assessment of insulin resistance (HOMA-IR) in the CHF group than in the control group, while insulin sensitivity index (ISI) and high-density lipoprotein cholesterol (HDL-C) increased markedly.